Aligned Genetics Inc (238120) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.058x

Based on the latest financial reports, Aligned Genetics Inc (238120) has a cash flow conversion efficiency ratio of -0.058x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.04 Billion ≈ $-1.38 Million USD) by net assets (₩35.50 Billion ≈ $24.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Aligned Genetics Inc - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Aligned Genetics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 238120 liabilities breakdown for a breakdown of total debt and financial obligations.

Aligned Genetics Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aligned Genetics Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Seoul Food KO:004410	-0.015x
Haoxi Health Technology Limited Class A Ordinary Shares NASDAQ:HAO	-0.064x
Battalion Oil Corp NYSE MKT:BATL	-1.381x
Wikana SA WAR:WIK	0.057x
Kedawung Setia Industrial Tbk JK:KDSI	0.025x
Routon Electronic Co Ltd SHG:600355	0.032x
Imago Mulia Persada Tbk PT JK:LFLO	-0.132x
WebCash Corporation KQ:053580	0.047x

Annual Cash Flow Conversion Efficiency for Aligned Genetics Inc (2015–2024)

The table below shows the annual cash flow conversion efficiency of Aligned Genetics Inc from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Aligned Genetics Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩35.49 Billion ≈ $24.05 Million	₩3.07 Billion ≈ $2.08 Million	0.086x	-5.07%
2023-12-31	₩31.31 Billion ≈ $21.22 Million	₩2.85 Billion ≈ $1.93 Million	0.091x	+18.10%
2022-12-31	₩28.85 Billion ≈ $19.55 Million	₩2.22 Billion ≈ $1.51 Million	0.077x	+1429.28%
2021-12-31	₩26.99 Billion ≈ $18.29 Million	₩135.97 Million ≈ $92.14K	0.005x	+203.10%
2020-12-31	₩21.46 Billion ≈ $14.55 Million	₩35.67 Million ≈ $24.17K	0.002x	-94.71%
2019-12-31	₩20.97 Billion ≈ $14.21 Million	₩659.29 Million ≈ $446.79K	0.031x	+137.58%
2018-12-31	₩20.89 Billion ≈ $14.16 Million	₩-1.75 Billion ≈ $-1.18 Million	-0.084x	-116.08%
2017-12-31	₩22.64 Billion ≈ $15.34 Million	₩-876.75 Million ≈ $-594.16K	-0.039x	+17.86%
2016-12-31	₩24.18 Billion ≈ $16.39 Million	₩-1.14 Billion ≈ $-772.65K	-0.047x	+18.73%
2015-12-31	₩6.06 Billion ≈ $4.11 Million	₩-351.72 Million ≈ $-238.36K	-0.058x	--

About Aligned Genetics Inc

KQ:238120 Korea Medical Devices

Market Cap

$41.78 Million

₩61.65 Billion KRW

Market Cap Rank

#22538 Global

#1528 in Korea

Share Price

₩4385.00

Change (1 day)

+1.62%

52-Week Range

₩3080.00 - ₩6050.00

All Time High

₩7875.00